arrow
S

Shannon Strom

satsuma pharmaceuticals, inc., durham, north carolina, usa
H指数:6
被引数:109

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical Development of Therapies for Charcot–Marie–Tooth Disease: Recommendations for Trial Design, Endpoints, and Regulatory Pathways

腓骨肌萎缩症治疗药物的临床开发:试验设计、终点指标及监管路径的建议

2026-09-120
OAAI
A multicenter, randomized, double-blind dose ranging study of glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler compared to the monocomponents and open-label tiotropiurn dry powder inhaler in patients with moderate-to-severe COPD (vol 120, pg 16, 2016)
2017-08-011
OAAI
A multicenter, randomized, double-blind dose-ranging study of glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler compared to the monocomponents and open-label tiotropium dry powder inhaler in patients with moderate-to-severe COPD
2016-11-0119
OAAI